Earnings Call Summary | MediWound(MDWD.US) Q1 2024 Earnings Conference
The following is a summary of the MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript:Financial Performance:MediWound reported Q1 2024 revenue of $5 million, a significant increase compared to $3.8
MediWound Optimistic With Rising Q1 Revenue
MediWound | 6-K: Report of foreign private issuer (related to financial reporting)
MediWound: Q1 Earnings Snapshot
Express News | Mediwound Ltd: Escharex(®) Phase III Study to Launch 2H 2024
Express News | MediWound Q1 2024 GAAP EPS $(1.05) Misses $(0.41) Estimate, Sales $4.964M Beat $4.668M Estimate
Earnings Flash (MDWD) MEDIWOUND Reports Q1 Revenue $5M, Vs. Street Est of $4.7M
07:01 AM EDT, 05/29/2024 (MT Newswires) -- Earnings Flash (MDWD) MEDIWOUND Reports Q1 Revenue $5M, vs. Street Est of $4.7M
Express News | Mediwound Q1 EPS USD -1.05
Express News | Mediwound Q1 Gross Profit USD 600 Thousand
Express News | Mediwound Q1 Revenue USD 5 Million Vs. Ibes Estimate USD 4.67 Million
Express News | Mediwound Q1 Net Income USD -9.7 Million
Express News | Mediwound Q1 Adjusted Ebitda USD -2.9 Million
Express News | Mediwound Reports First Quarter 2024 Financial Results and Provides Company Update
MediWound 1Q Loss $9.73M >MDWD
MediWound 1Q Loss $9.73M >MDWD
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
NexoBrid interest surges; $5 million in Q1 2024 revenue, with $24 million forecast for the yearManufacturing facility on target for completion by mid-2024EscharEx Phase III study to launch 2H 2024Comp
MediWound to Report First Quarter 2024 Financial Results
Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern TimeYAVNE, Israel, May 22, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generati
MediWound Ltd.'s (NASDAQ:MDWD) P/S Is Still On The Mark Following 25% Share Price Bounce
Despite an already strong run, MediWound Ltd. (NASDAQ:MDWD) shares have been powering on, with a gain of 25% in the last thirty days. Looking back a bit further, it's encouraging to see the stock i
MediWound to Present New Data From EscharEx Phase II Studies at Three Leading Wound Care Conferences
Oral presentations include additional comparative data between EscharEx and SANTYL, and new analyses show strong correlation between wound bed preparation and wound healingAnalyses validate the planne
Analysts Are Bullish on Top Healthcare Stocks: Mediwound (MDWD), Ironwood Pharma (IRWD)
Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?
No Data